Saffron has been used medicinally for 4,000 years, to treat at least 90 different illnesses. But in supplements today, it's become an evidence-based, natural mood booster that rivals pharmaceuticals ...
Subclinical depression is a mild form of depression where an individual experiences some typical symptoms—such as sadness or loss of interest—but does not meet the full diagnostic criteria for major ...
Should you suffer from insomnia, you'll know how tempting it can be to rely on sleep-aid drugs. A new study, however, suggests that insomniacs may have success with a natural supplement, in the form ...
Saffron extract recently made headlines after television's most popular doctor, Dr. Mehmet Oz, promoted the supplement on his show. Dr. Oz revealed saffron extract as a natural appetite suppressant.
Thanks to increased awareness, depression is being recognized as a real health issue that demands attention. While medical intervention is often required to manage symptoms like anxiety and insomnia, ...
Results from a new, large-scale clinical study demonstrate Pharmactive Biotech Products, S.L.U.’s flagship saffron extract Affron could help lift the mood in people suffering from mild depressive ...
Growing evidence suggests this ancient spice can play a role in treating a wide range of health conditions Sue Quinn is an ...
New research has shown that saffron may assist adults with depression when it is taken in conjunction with pharmaceutical antidepressants. Murdoch University researchers Dr. Adrian Lopresti and ...
If you have been suffering from a low sex drive and need a little something to get in the mood, you'll be surprised to know that a spice you can find in your kitchen is also an amazing herbal ...
On the islands of Crete and Santorini, there are millenia-old frescoes depicting girls and monkeys harvesting flowers: saffron crocuses, whose scarlet stigmas, when plucked and dried, become that most ...
Large clinical study reveals Affron® brand saffron's potential as a natural long-term solution to mild depressive symptoms MADRID, June 24, 2025 /PRNewswire/ -- Results from a new, large-scale ...